Skip to main content

Cearnal Martin E's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) ยท filed Jul 9, 2021

Accession no.
0001209191-21-046210
Filed
Jul 9, 2021
Trade date
May 18-Jun 29, 2021
Filing delay
52 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 30 non-derivative transactions. Open-market purchases total $9.50K. It was filed 52 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Cearnal Martin ECIK 0001408500Director, Officer (Sr VP/Chief Commercial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 18, 2021Common StockPPurchaseAcquired+105$2.91+$305.55161,904Direct
May 19, 2021Common StockPPurchaseAcquired+105$2.83+$297.15162,009Direct
May 20, 2021Common StockPPurchaseAcquired+105$2.94+$308.7162,114Direct
May 21, 2021Common StockPPurchaseAcquired+105$3.06+$321.3162,219Direct
May 24, 2021Common StockPPurchaseAcquired+105$3.02+$317.1162,324Direct
May 25, 2021Common StockPPurchaseAcquired+105$2.89+$303.45162,429Direct
May 26, 2021Common StockPPurchaseAcquired+105$2.85+$299.25162,534Direct
May 27, 2021Common StockPPurchaseAcquired+105$2.94+$308.7162,639Direct
May 28, 2021Common StockPPurchaseAcquired+105$2.93+$307.65162,744Direct
Jun 1, 2021Common StockPPurchaseAcquired+105$2.94+$308.7162,849Direct
Jun 2, 2021Common StockPPurchaseAcquired+105$2.89+$303.45162,954Direct
Jun 3, 2021Common StockPPurchaseAcquired+105$2.81+$295.05163,059Direct
Jun 4, 2021Common StockPPurchaseAcquired+105$2.93+$307.65163,164Direct
Jun 7, 2021Common StockPPurchaseAcquired+105$2.94+$308.7163,269Direct
Jun 8, 2021Common StockPPurchaseAcquired+105$2.99+$313.95163,374Direct
Jun 9, 2021Common StockPPurchaseAcquired+105$3.14+$329.7163,479Direct
Jun 10, 2021Common StockPPurchaseAcquired+105$3.25+$341.25163,584Direct
Jun 11, 2021Common StockPPurchaseAcquired+105$3.18+$333.9163,689Direct
Jun 14, 2021Common StockPPurchaseAcquired+105$3.11+$326.55163,794Direct
Jun 15, 2021Common StockPPurchaseAcquired+105$3.09+$324.45163,899Direct
Jun 16, 2021Common StockPPurchaseAcquired+105$3.09+$324.45164,004Direct
Jun 17, 2021Common StockPPurchaseAcquired+105$3.08+$323.4164,109Direct
Jun 18, 2021Common StockPPurchaseAcquired+105$2.99+$313.95164,214Direct
Jun 21, 2021Common StockPPurchaseAcquired+105$3.14+$329.7164,319Direct
Jun 22, 2021Common StockPPurchaseAcquired+105$3.05+$320.25164,424Direct
Jun 23, 2021Common StockPPurchaseAcquired+105$3.07+$322.35164,529Direct
Jun 24, 2021Common StockPPurchaseAcquired+105$3.09+$324.45164,634Direct
Jun 25, 2021Common StockPPurchaseAcquired+105$3.09+$324.45164,739Direct
Jun 28, 2021Common StockPPurchaseAcquired+105$3.16+$331.8164,844Direct
Jun 29, 2021Common StockPPurchaseAcquired+105$3.03+$318.15164,949Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)